Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-16

Clinical Trial Update: Switching to Very Low Nicotine Content Cigarettes vs Reducing Cigarettes Per Day [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial compared switching to very low nicotine content cigarettes with reducing cigarettes per day in tobacco use disorder; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Vermont | Conditions: Tobacco Use Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-09-16